ATE312635T1 - Ventilanordnung - Google Patents

Ventilanordnung

Info

Publication number
ATE312635T1
ATE312635T1 AT01909634T AT01909634T ATE312635T1 AT E312635 T1 ATE312635 T1 AT E312635T1 AT 01909634 T AT01909634 T AT 01909634T AT 01909634 T AT01909634 T AT 01909634T AT E312635 T1 ATE312635 T1 AT E312635T1
Authority
AT
Austria
Prior art keywords
valve arrangement
arrangement
valve
patient
providing
Prior art date
Application number
AT01909634T
Other languages
English (en)
Inventor
Ignacio Larrain
Michael Jedwab
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Application granted granted Critical
Publication of ATE312635T1 publication Critical patent/ATE312635T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16804—Flow controllers
    • A61M5/16827—Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16877—Adjusting flow; Devices for setting a flow rate
    • A61M5/16881—Regulating valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/60—General characteristics of the apparatus with identification means
    • A61M2205/6045—General characteristics of the apparatus with identification means having complementary physical shapes for indexing or registration purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22—Valves or arrangement of valves
    • A61M39/24—Check- or non-return valves
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/7722—Line condition change responsive valves
    • Y10T137/7837—Direct response valves [i.e., check valve type]
    • Y10T137/7838—Plural

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Magnetically Actuated Valves (AREA)
  • Compressor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01909634T 2000-01-20 2001-01-17 Ventilanordnung ATE312635T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0001309A GB0001309D0 (en) 2000-01-20 2000-01-20 Valve arrangement
PCT/EP2001/000450 WO2001052921A2 (en) 2000-01-20 2001-01-17 Valve arrangement

Publications (1)

Publication Number Publication Date
ATE312635T1 true ATE312635T1 (de) 2005-12-15

Family

ID=9884033

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01909634T ATE312635T1 (de) 2000-01-20 2001-01-17 Ventilanordnung

Country Status (6)

Country Link
US (1) US6843780B2 (de)
EP (1) EP1251894B1 (de)
AT (1) ATE312635T1 (de)
DE (1) DE60115842D1 (de)
GB (1) GB0001309D0 (de)
WO (1) WO2001052921A2 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
US7094216B2 (en) 2000-10-18 2006-08-22 Medrad, Inc. Injection system having a pressure isolation mechanism and/or a handheld controller
EP1587482A4 (de) * 2003-01-31 2010-08-25 Technion Res & Dev Foundation Entzündungshemmende zusammensetzungen und ihre verwendungen
US8129514B2 (en) 2003-06-19 2012-03-06 Evogene Ltd. Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
US7498428B2 (en) * 2003-06-19 2009-03-03 Evogene Ltd. Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
WO2005110007A2 (en) * 2004-04-12 2005-11-24 Medrad, Inc. Fluid delivery systems, pressure isolation mechanisms, injector control mechanisms, and methods of use thereof
EP1843819A2 (de) * 2004-11-15 2007-10-17 Obe Therapy Biotechnology S.A.S. Verfahren zur reduzierung von körperfett
US9433730B2 (en) 2013-03-14 2016-09-06 Bayer Healthcare Llc Fluid mixing control device for a multi-fluid delivery system
US7766883B2 (en) 2007-10-30 2010-08-03 Medrad, Inc. System and method for proportional mixing and continuous delivery of fluids
US9011377B2 (en) 2008-11-05 2015-04-21 Bayer Medical Care Inc. Fluid mixing control device for a multi-fluid delivery system
CA2604760C (en) 2005-05-23 2012-06-26 Cadbury Adams Usa Llc Taste potentiator compositions and beverages containing same
WO2006131115A1 (en) * 2005-06-04 2006-12-14 Danfoss A/S Connector for a flow system
US20070225242A1 (en) * 2005-06-21 2007-09-27 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for treating and preventing tumor metastasis in vivo
ES2435774T3 (es) 2005-07-07 2013-12-23 Yissum Research Development Company, Of The Hebrew University Of Jerusalem Agentes de ácido nucleico para la regulación negativa de H19, y métodos de uso del mismo
US20080097389A1 (en) * 2006-07-10 2008-04-24 Wilson Roland B Y-type blood transfusion set
WO2008087642A2 (en) * 2007-01-16 2008-07-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nucleic acid constructs and methods for specific silencing of h19
IL184627A0 (en) 2007-07-15 2008-12-29 Technion Res & Dev Foundation Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
ES2402334T3 (es) 2007-08-02 2013-04-30 Gilead Biologics, Inc Procedimientos y composiciones para el tratamiento y el diagnóstico de la fibrosis
US8097712B2 (en) 2007-11-07 2012-01-17 Beelogics Inc. Compositions for conferring tolerance to viral disease in social insects, and the use thereof
EP3587434A1 (de) 2008-09-23 2020-01-01 Alnylam Pharmaceuticals Inc. Chemische modifikationen von monomeren und oligonukleotiden mit click komponenten um liganden zu konjugieren
US9107935B2 (en) * 2009-01-06 2015-08-18 Gilead Biologics, Inc. Chemotherapeutic methods and compositions
US8052656B2 (en) * 2009-02-10 2011-11-08 Tyco Healthcare Group Lp Enteral feeding system
US20100286650A1 (en) * 2009-05-07 2010-11-11 Alan Fitzgerald Medical Fluid Container
WO2011022670A1 (en) * 2009-08-21 2011-02-24 Arresto Biosciences, Inc In vivo screening assays
CN102711821A (zh) * 2009-08-21 2012-10-03 吉联亚生物科技有限公司 治疗方法和组合物
SG178845A1 (en) 2009-08-21 2012-04-27 Gilead Biologics Inc Catalytic domains from lysyl oxidase and loxl2
CN102711820A (zh) * 2009-08-21 2012-10-03 吉联亚生物科技有限公司 治疗肺纤维化疾病的方法和组合物
US20110207144A1 (en) * 2009-08-21 2011-08-25 Derek Marshall In vitro screening assays
BR112012008078A2 (pt) 2009-08-21 2017-07-04 Beeologics Inc prevenção e cura de doenças de inseto benéfico por meio de moléculas transcritas de planta.
US9610331B2 (en) 2009-09-08 2017-04-04 Yeda Research And Development Co. Ltd. Methods for hematopoietic precursor mobilization
MX353880B (es) 2009-10-14 2018-01-31 Yissum Research Development Company Of The Hebrew Univ Of Jerusalem Ltd Star Composiciones para controlar ácaros varroa en abejas.
US8962584B2 (en) 2009-10-14 2015-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Compositions for controlling Varroa mites in bees
BR112012019693A2 (pt) 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
US9518988B2 (en) 2010-04-18 2016-12-13 Yeda Research And Development Co. Ltd. Antibodies and methods of using same for treating ErbB/ErbB ligands associated diseases
US20130260460A1 (en) 2010-04-22 2013-10-03 Isis Pharmaceuticals Inc Conformationally restricted dinucleotide monomers and oligonucleotides
US10913767B2 (en) 2010-04-22 2021-02-09 Alnylam Pharmaceuticals, Inc. Oligonucleotides comprising acyclic and abasic nucleosides and analogs
EP2582842A2 (de) 2010-06-16 2013-04-24 Yissum Research Development Company of The Hebrew University of Jerusalem Verfahren zur diagnose und behandlung von krebs
US8689439B2 (en) 2010-08-06 2014-04-08 Abbott Laboratories Method for forming a tube for use with a pump delivery system
CN103210082A (zh) 2010-09-15 2013-07-17 雷蒙特亚特特拉维夫大学有限公司 扩增胰岛β细胞和使其再分化的方法
US8377000B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Enteral feeding apparatus having a feeding set
US8377001B2 (en) 2010-10-01 2013-02-19 Abbott Laboratories Feeding set for a peristaltic pump system
EP3075396A1 (de) 2010-10-17 2016-10-05 Yeda Research and Development Co. Ltd. Verfahren und zusammensetzungen zur behandlung von insulinassoziierten erkrankungen
WO2012172555A1 (en) 2011-06-14 2012-12-20 Yeda Research And Development Co. Ltd. Combination therapy to prevent dcis formation and progression to breast cancer
WO2013021389A2 (en) 2011-08-09 2013-02-14 Yeda Research And Development Co.Ltd. Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
WO2013076730A1 (en) 2011-11-27 2013-05-30 Yeda Research And Development Co. Ltd. Methods of regulating angiogenesis and compositions capable of same
EP2844745A2 (de) 2012-02-22 2015-03-11 Brainstem Biotec Ltd. Erzeugung von neuralen stammzellen und motorneuronen
MX359191B (es) 2013-07-19 2018-09-18 Monsanto Technology Llc Composiciones y métodos para controlar leptinotarsa.
UY35817A (es) 2013-11-04 2015-05-29 Us Agriculture ?composiciones y métodos para controlar infestaciones de plagas y parásitos de los artrópodos?.
EP3420809A1 (de) 2014-04-01 2019-01-02 Monsanto Technology LLC Zusammensetzungen und verfahren zur bekämpfung von insektenbefall
US9345829B2 (en) * 2014-04-27 2016-05-24 Joe Lomick Infusion device for IV drugs that are incompatible to each other
WO2016018887A1 (en) 2014-07-29 2016-02-04 Monsanto Technology Llc Compositions and methods for controlling insect pests
CN108064274A (zh) 2014-07-30 2018-05-22 耶达研究及发展有限公司 用于培养多能干细胞的培养基
WO2016030899A1 (en) 2014-08-28 2016-03-03 Yeda Research And Development Co. Ltd. Methods of treating amyotrophic lateral scleroses
EP3220945A2 (de) 2014-11-17 2017-09-27 Yeda Research and Development Co., Ltd. Verfahren zur behandlung von krankheiten im zusammenhang mit der mitochondrienfunktion
US20180345047A1 (en) 2015-02-26 2018-12-06 Yeda Research And Development Co. Ltd. Method of promoting hair growth
CN107810404B (zh) 2015-03-24 2020-11-10 伊鲁米那股份有限公司 用于对样品成像用于生物或化学分析的方法、载体组件和系统
EP3280401B1 (de) 2015-04-07 2021-08-25 ELA Pharma Ltd Zusammensetzungen zur behandlung und/oder vorbeugung von zell- oder gewebe-nekrosen durch targeting von cathepsin c und/oder cela1 und/oder cela3a und/oder strukturell verwandten enzymen
BR112017023754B1 (pt) 2015-05-04 2022-08-09 Beeologics, Inc. Composições inseticidas, e uso de um ácido nucleico
US20180161300A1 (en) 2015-05-11 2018-06-14 Yeda Research And Development Co., Ltd. Citrin inhibitors for the treatment of cancer
WO2016185457A1 (en) 2015-05-19 2016-11-24 Yeda Research And Development Co. Ltd. Methods of promoting lymphangiogenesis
CA2986203A1 (en) 2015-05-21 2016-11-24 Yeda Research And Development Co. Ltd. Bacterial populations for promoting health
EP3331546B1 (de) 2015-08-03 2023-10-04 Biokine Therapeutics Ltd. Cxcr4-antagonist zur behandlung von krebs
WO2017102624A1 (en) * 2015-12-16 2017-06-22 Nestec S.A. Valve arrangement for enteral feeding sets having multiple fluid sources
CN108472445A (zh) * 2015-12-16 2018-08-31 阿克西姆医疗技术有限公司 用于具有多个流体源的肠内输注组的阀布置
JP2019505511A (ja) 2016-01-06 2019-02-28 イェダ リサーチ アンド ディベロップメント カンパニー リミテッドＹｅｄａ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏ．Ｌｔｄ． 悪性疾患、自己免疫疾患および炎症性疾患を処置するための組成物および方法
WO2017153982A1 (en) 2016-03-06 2017-09-14 Yeda Research And Development Co. Ltd. Method for modulating myelination
WO2019116376A1 (en) 2017-12-17 2019-06-20 Yeda Research And Development Co. Ltd. Cop9 signalosome (csn) complex modulators and uses thereof
MX2020011570A (es) 2018-05-07 2020-11-24 Alnylam Pharmaceuticals Inc Administracion extrahepatica.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3119411A (en) * 1957-12-21 1964-01-28 Rau Swf Autozubehoer Valved t-pipe joint, particularly for windshield washing apparatus
US4210173A (en) * 1976-12-06 1980-07-01 American Hospital Supply Corporation Syringe pumping system with valves
US4573974A (en) * 1982-12-01 1986-03-04 Baxter Travenol Laboratories, Inc. Medical administration set enabling sequential delivery of two liquids at different flow rate
US4729401A (en) * 1987-01-29 1988-03-08 Burron Medical Inc. Aspiration assembly having dual co-axial check valves
US5356375A (en) * 1992-04-06 1994-10-18 Namic U.S.A. Corporation Positive pressure fluid delivery and waste removal system
US5354272A (en) * 1993-03-02 1994-10-11 Baxter International Inc. Improved injectate delivery system
US5738662A (en) * 1996-02-21 1998-04-14 Pacific Device/Avail Medical Products, Inc. Retrograde flow checked manifold for infusing medical fluids
DE19643360C1 (de) * 1996-10-21 1998-05-14 Jan Willem Marinus Ing Myers Membranventil in Drei-Wege-Ausführung, insbesondere für die medizintechnische Anwendung
IL120654A (en) 1997-04-11 2001-08-08 Nestle Sa Administration of two liquids to a patient

Also Published As

Publication number Publication date
US20030017068A1 (en) 2003-01-23
WO2001052921A3 (en) 2002-01-31
DE60115842D1 (de) 2006-01-19
EP1251894A2 (de) 2002-10-30
WO2001052921A2 (en) 2001-07-26
US6843780B2 (en) 2005-01-18
GB0001309D0 (en) 2000-03-08
EP1251894B1 (de) 2005-12-14

Similar Documents

Publication Publication Date Title
ATE312635T1 (de) Ventilanordnung
BG108443A (en) Substituted oxazoliidinones for combinational therapy
AU2005202257C1 (en) Azacyclic compounds for use in the treatment of serotonin related diseases
TW200505900A (en) Muscarinic agonists
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
SE9702860D0 (sv) New use
HUP0202776A2 (hu) (+)-Tramadol, O-demetil-tramadol, (+)-O-demetil-tramadol, O-demetil-N-mono-demetil-tramadol, illetve (+)-O-demetil-N-mono-demetil-tramadol felhasználása vizeletinkontinencia kezelésére alkalmas gyógyszerkészítmény előállítására
SE0300098D0 (sv) Use of cyclin D1 inhibitors
GB0020504D0 (en) Therapeutic method
MY135460A (en) Method of stimulating hair growth using benzopyrans
SE0402507D0 (sv) Medicinsk lösning, förfarande för framställning och användning därav
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
SE0101256D0 (sv) Treatment of low back pain
SI1596879T1 (sl) Uporaba spojine kahalalida za pripravo zdravila za zdravljenje luskavice
DE602004025683D1 (de) Therapeutische zubereitung für autoimmune erkrankungen
DE50005714D1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components
UA40330A (uk) Спосіб лікування запальних захворювань пародонту
UA30840A (uk) Спосіб лікування гострого калькульозного пієлонефриту
UA36490A (uk) Спосіб лікування гнійно-септичних захворювань м'яких тканин
UA33487A (uk) Спосіб лікування підгострих запалювальних захворювань придатків матки
UA4292U (uk) Спосіб лікування альвеолітів

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties